A trial to test the safety of a herbal drug.

Phase 1 clinical trial for assessment of safety of a multi component botanical therapeutic SKBRAM.

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/11/010617

Enrollment

100

Registered

2017-11-23

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: SKBRAM: Dose: 5-6 drops Frequency: Every hour Route of administration: Put drops on nail and allow to absorb from boundaries of nail. Duration of Therapy: minimum 15 days. Control Inte

Eligibility

Inclusion criteria

Inclusion criteria: Healthy Human Volunteers

Exclusion criteria

Exclusion criteria: Patients suffering from any disease.

Design outcomes

Primary

Measure	Time frame
Any toxic side effects after application of SKBRAM on nail such as breaking of nail, irritation, ulcers, fever, nausea , vomiting, cough, shortness of breath, diarrhea, numbness, paralysis, depression, anxiety, skin rashes, choking, palpitations etc.Timepoint: 1 day	—

Secondary

Measure	Time frame
Any toxic side effects after application of SKBRAM on nail such as breaking of nail, irritation, ulcers, fever, nausea , vomiting, cough, shortness of breath, diarrhea, numbness, paralysis, depression, anxiety, skin rashes, choking, palpitations etc.Timepoint: 15 days	—

Countries

India

Contacts

Public ContactAshok Kumar

SK Biotherapeutics Pvt. Ltd. (Previously SK Biolabs)

ashok846@gmail.com8126688922

Outcome results